{
    "Orphapacket": {
        "ORPHApacketId": "563581",
        "creationDate": "2023-06-22 11:33:23",
        "version": "1.3.25 / 4.1.7 [2023-04-17] (orientdb version)",
        "copyright": "Orphanet (c) 2023",
        "ORPHAcode": "563581",
        "Label": "Autoimmune hepatitis type 2",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_563581",
        "DisorderType": {
            "value": "Clinical subtype",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377796"
        },
        "Synonyms": [
            {
                "Synonym": "AIH type 2"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "A form of autoimmune hepatitis characterized by clinical presentation as cryptogenic hepatitis interface hepatitis on histological examination elevated serum aminotransferase levels hypergammaglobulinemia/elevated immunoglobulin G and presence of circulating autoantibodies specifically antibodies to liver kidney microsome type 1 (anti-LKM1) and anti-liver cytosol type 1 (anti-LC1) antibodies. The disease typically manifests in childhood or adolescence with an acute onset often with acute liver failure. Long-term immunosuppression is usually required. Reported concurrent autoimmune diseases are autoimmune thyroiditis diabetes mellitus and vitiligo."
        },
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "2137",
                        "Label": "Autoimmune hepatitis"
                    }
                ]
            }
        ],
        "AverageAgeOfOnsets": [
            {
                "AverageAgeOfOnset": {
                    "value": "Adolescent"
                }
            },
            {
                "AverageAgeOfOnset": {
                    "value": "Adult"
                }
            },
            {
                "AverageAgeOfOnset": {
                    "value": "Childhood"
                }
            }
        ]
    }
}